Results 261 to 266 of about 12,455 (266)

Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection.

Vaccine, 2023
Albert To, T. Wong, Aquena H. Ball, Michael M. Lieberman, J. Yalley-Ogunro, M. Cabus, Sara Nezami, Fabian Paz, Hanne A. Elyard, V. Borisevich, K. Agans, D. Deer, Courtney Woolsey, R. Cross, T. Geisbert, O. Donini, A. Lehrer   +16 more
semanticscholar   +1 more source

Modeling Ebolavirus Budding with Virus Like Particles

2017
About 15 years ago, several groups initially described the release of virus like particles (VLPs) upon expression of Ebola virus VP40 in mammalian cells. Further development of the protocol later allowed for the dissection of the Ebola virus budding mechanism and for the identification of critical VP40 residues involved in this process.
Mathieu Mateo, Mathieu Mateo, Olivier Reynard   +2 more
openaire   +6 more sources

The C-terminus of Sudan ebolavirus VP40 contains a functionally important CXnC motif, a target for redox modifications.

Structure, 2023
Anke-Dorothee Werner, Martin Schauflinger, M. Norris, Michael Klüver, Anna Trodler, A. Herwig, C. Brandstädter, Melissa Dillenberger, G. Klebe, A. Heine, E. Saphire, Katja Becker, S. Becker   +12 more
semanticscholar   +1 more source

Characterization of Ebolavirus Entry

2019
Ebola virus disease is a global concern given its periodic occurrence, high lethality, and rapid spread, coupled with a lack of approved therapeutics and vaccines. New tools are needed to gain fundamental insight into the virus life cycle, particularly entry and fusion of the viral envelope with the host membrane, and to combat the spread of the ...
openaire   +2 more sources

Editorial: Laboratory preparedness for Ebolavirus disease

Pathology, 2015
Sharon C.-A. Chen, Sharon C.-A. Chen, Dominic E. Dwyer, Dominic E. Dwyer, Jen Kok, Jen Kok, Vitali Sintchenko, Vitali Sintchenko   +7 more
openaire   +3 more sources

Ebolavirus: evidence-based speculations

2014
openaire   +2 more sources